(October 03 20:59) Forbes.com
Like influenza, SARS-CoV-2 is an expert at mutating and evading prior immunity. This includes vaccine-induced immunity. New research suggests that expanding the target area of our vaccines to include the virus' nucleocapsid protein may offer stronger and broader protection.
You can find the original article
here